Skip to Main Content
American Flag
LABOR DAY SALE

50% off your first year of any Quiver subscription

...

Use Promo Code:

LABOR26
American Flag
×
Quiver Logo Get a Free Trial on Quiver Premium Today!
Back to News

Rapid Micro Biosystems Revenue Rises 22% to $9.5 Million in Q3

None

Rapid Micro Biosystems (RPID) reported third-quarter 2026 revenue of $9.5 million, up 21.6% from $7.8 million a year earlier. Net loss was $11.3 million, or $0.23 per basic and diluted share, compared with a $11.5 million loss, or $0.26 per share, in the prior-year quarter.

The company also announced a definitive agreement to be acquired by Merck KGaA, Darmstadt, Germany. Rapid Micro said it will not hold an earnings conference call, withdrew full-year 2026 guidance, and expects to delay its Form 10-Q filing within the permitted extension period.

  • Total gross margin was 25.2%, compared with 8.9% in the third quarter of 2025.
  • Product revenue increased 24.9% to $6.5 million, while service revenue rose 14.9% to $3.0 million.
  • The company placed seven Growth Direct systems and completed 12 customer-system validations during the quarter.
  • Cash, cash equivalents and short-term investments were approximately $7 million as of September 30, 2026.

$RPID Hedge Fund Activity

We have seen 21 institutional investors add shares of $RPID stock to their portfolio, and 30 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

Add Quiver Quantitative to your preferred sources on Google Google News Logo

Suggested Articles